Refine
Year of publication
Document Type
- Article (70) (remove)
Language
- English (70) (remove)
Has Fulltext
- yes (70)
Is part of the Bibliography
- no (70)
Keywords
- Magnetic resonance imaging (6)
- CT (4)
- Hepatocellular carcinoma (4)
- MRI (4)
- Artificial intelligence (3)
- Cancer (3)
- microwave ablation (3)
- Algorithms (2)
- Bone density (2)
- DSM (2)
- Dynamic MRI (2)
- Machine learning (2)
- Microwave ablation (2)
- Multidetector computed tomography (2)
- Neoplasms (2)
- Osteoporosis (2)
- Prostate cancer (2)
- Radiomics (2)
- Spine (2)
- Tomography (x-ray computed) (2)
- Transarterial chemoembolization (2)
- breast cancer (2)
- computed tomography (2)
- hepatocellular carcinoma (2)
- liver (2)
- 16 segment AHA model (1)
- Ablation Techniques (1)
- Age determination by skeleton (1)
- Anemia (1)
- Angiography (1)
- Aromatase Inhibitors (1)
- Automated Tube Potential Selection (1)
- Berci needle (1)
- Biopsy (1)
- Blood (1)
- Bone diseases, Metabolic (1)
- Bone marrow (1)
- Breast tumors (1)
- COVID-19 (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CT-guided interventions (1)
- Calcium (1)
- Cancer Staging (1)
- Cancer staging (1)
- Carcinoma, Ductal, Breast (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic resonance (1)
- Cell binding (1)
- Cell staining (1)
- Chemoembolization (1)
- Children (1)
- Chondral Lesion (1)
- Cochlear implantation (1)
- Cohort studies (1)
- Colchicum (1)
- Computed tomography imaging (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Cone-beam computed tomography (1)
- Congenital (1)
- Contrast agent (1)
- Diagnostic differentiation (1)
- Diagnostic imaging (1)
- Diagnostic markers (1)
- Diffusion magnetic resonance imaging (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- Dumon stents (1)
- Edema (1)
- Electric stimulation (1)
- Estrogen Receptor Modulators (1)
- Exudates and transudates (1)
- Facial nerve (1)
- Feasibility studies (1)
- Fetal heart (1)
- First experience with patients (1)
- Flow cytometry (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Goserelin (1)
- Groin pain (1)
- HCC (1)
- Heart defects (1)
- Herniated disk (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- In-TIPS thrombosis (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Intensive care units (1)
- Interventional oncological treatment (1)
- Intervertebral disc displacement (1)
- Kupffer cells (1)
- LNS (1)
- Laser interstitial thermal therapy (1)
- Laser navigation system (1)
- Lateral recess stenosis (1)
- Lipidol (1)
- Lipiodol (1)
- Liver (1)
- Local control (1)
- Low back pain (1)
- Lumbar spinal canal stenosis (1)
- Lumbar spine (1)
- Lung neoplasms (1)
- Lymphangioleiomyomatosis (1)
- MEDIC (1)
- Macrophages (1)
- Mastoiditis (1)
- Medical Oncology (1)
- Medical research (1)
- Metastasis (1)
- Mitomycin C (1)
- Mouse models (1)
- Multidetector Computed Tomography (1)
- Multiparametric MRI (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- Myocarditis (1)
- Necrotic area (1)
- Noninferiority (1)
- Nonpenetrating (1)
- Oncology (1)
- Osteoporotic fractures (1)
- Oswestry Disability Score (1)
- Patellofemoral Joint (1)
- Percutaneous (1)
- Phantom study (1)
- Phantoms (imaging) (1)
- Physics (1)
- Portal (1)
- Positron emission tomography (1)
- Preclinical research (1)
- Prediction (1)
- Predictive markers (1)
- Prognostic markers (1)
- Quantitative Imaging (1)
- Quantitative features (1)
- Radiology (1)
- Renal lesions (1)
- Response (1)
- Retrospective studies (1)
- Retrospective study (1)
- STIR (1)
- Shunt (1)
- Spinal fractures (1)
- Spinal injuries (1)
- Static MRI (1)
- Statistical analysis (1)
- Sub-segmentation (1)
- Survival (1)
- Survival data (1)
- TACE (1)
- TIPS (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Thrombosis (1)
- Tomography (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Translational research (1)
- Treatment outcome (1)
- Truncus arteriosus (1)
- Tumor volume (1)
- UWB diagnostics (1)
- Vaccination (1)
- Vasculitis (1)
- Vertebral body (1)
- Virtual noncalcium reconstructions (1)
- Wounds (1)
- X-ray computed (1)
- abdominal imaging (1)
- airway (1)
- amino acids (1)
- angiography (1)
- aortic stenosis (1)
- beads (1)
- biopsy (1)
- cardiac magnetic resonance (1)
- cardiac remodeling (1)
- chronic liver disease (CLD) (1)
- cisplatin (1)
- colorectal cancer (1)
- colorectal cancer (CRC) (1)
- colorectal cancer liver metastases (CRLM) (1)
- computer tomography (1)
- computer-assisted (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- conventional/traditional transarterial chemoembolization (cTACE) (1)
- critical care unit (1)
- critical ill patients (1)
- denervation (1)
- diagnostic imaging (1)
- drug-eluting beads TACE (DEB-TACE) (1)
- dual-energy (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- heart failure (1)
- hepatocellular carcinoma (HCC) (1)
- high-pitch (1)
- imaging (1)
- in vivo dosimetry (1)
- interventional radiology (1)
- intraarterial therapy (1)
- intratumoral (1)
- irinotecan-loaded drug-eluting beads TACE (DEBIRI-TACE) (1)
- laser-induced thermotherapy (1)
- lipiodol (1)
- liver metastases (1)
- livermetastases of colorectal cancer (1)
- locoregional chemotherapy (1)
- low-dose imaging (1)
- lung cancer (1)
- mantle cell lymphoma (1)
- microwave breast imaging (1)
- multidetector computed tomography (1)
- myocardial fibrosis (1)
- non‑Hodgkin's lymphoma (1)
- oval split ring resonator (1)
- overall survival (OS) (1)
- papilloma (1)
- patient study (1)
- percutaneous thermal ablation (1)
- peripheral blood stem cell transplant (1)
- portal vein (1)
- progression-free survival (PFS) (1)
- pulmonary hypertension (1)
- radiation (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiomics (1)
- rats (1)
- retuximab (1)
- scar (1)
- sepsis (1)
- sex‑determining region Y-box 11 (1)
- skin involvement (1)
- solitary pulmonary nodule (1)
- spine (1)
- stent (1)
- theranostics (1)
- thrombosis (1)
- tracheobronchomalacia (1)
- transarterial chemoembolization (TACE) (1)
- transbronchial biopsy (TBB) (1)
- tumor response (1)
- vertebroplasty (1)
Institute
- Medizin (70)
- Informatik und Mathematik (3)
- Informatik (1)
- Physik (1)
- Sonderforschungsbereiche / Forschungskollegs (1)
To analyze prospectively the interventional and clinical aspects of computed tomography-guided direct intratumoural injection of a novel chemotherapeutic administration and the parenchymal changes of tumour and necrosis in malignant liver tumours. Eight patients with 17 colorectal liver metastases were treated with a mean of 5.1 injections and nine patients with 13 hepatocellular carcinoma nodules with a mean of 3.1 treatments with computed tomography guided local applications of a novel cisplatin/epinephrine gel. This application provides a higher local and lower systemic drug concentration. Volumes of tumour and necrosis prior and after treatment were measured by computer generated volumetric analysis. Contrast enhanced studies verified pretherapeutic viable tumour volumes with a value of 77.4 ml in the metastases and 29.2 ml in the hepatocellular carcinoma nodules. Intratumoural drug application resulted in a significant increase of necrosis and a decrease in viable tumour volume to be 68.3 ml in metastases and 14.5 ml in hepatocellular carcinoma. Local therapy control rate for the follow up to 6 months was 38 and 71% for the group of metastases and hepatocellular carcinoma, respectively. Direct intratumoural injection of cisplatin/epinepthrine injectable gel is a feasible and good tolerated method and results in the development of a statistically significant increase in necrosis in malignant liver tumours. For hepatocellular carcinoma a higher local therapy control rate compared to colorectal metastases can be reported.
AIM: To evaluate and compare the effect of combined transarterial chemoembolization (TACE) and arterial administration of Bletilla striata (a Chinese traditional medicine against liver tumor) versus TACE alone for the treatment of hepatocellular carcinoma (HCC) in ACI rats.
METHODS: Subcapsular implantation of a solid Morris hepatoma 3 924A (2 mm3) in the liver was carried out in 30 male ACI rats. Tumor volume (V1) was measured by magnetic resonance imaging (MRI) on day 13 after implantation. The following different agents of interventional treatment were injected after retrograde catheterization via gastroduodenal artery (on day 14), namely, (A) TACE (0.1 mg mitomycin + 0.1 ml Lipiodol) + Bletilla striata (1.0 mg) (n=10); (B) TACE + Bletilla striata (1.0 mg) + ligation of hepatic artery (n=10), (C) TACE alone (control group, n=10). Tumor volume (V2) was assessed by MRI (on day 13 after treatment) and the tumor growth ratio (V2/V1) was calculated.
RESULTS: The mean tumor volume before (V1) and after (V2) treatment was 0.0355 cm3 and 0.2248 cm3 in group A, 0.0374 cm3 and 0.0573 cm3 in group B, 0.0380 cm3 and 0.3674 cm3 in group C, respectively. The mean ratio (V2/V1) was 6.2791 in group A, 1.5324 in group B and 9.1382 in group C. Compared with the control group (group C), group B showed significant inhibition of tumor growth (P<0.01), while group A did not (P>0.05). None of the animals died during implantation or in the postoperative period.
CONCLUSION: Combination of TACE and arterial administration of Bletilla striata plus ligation of hepatic artery is more effective than TACE alone in the treatment of HCC in rats.
The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three blinded readers (‘average reader’) was 83.7% for gadobutrol and 87.3% for gadopentate dimeglumine. The increase in accuracy from precontrast to combined precontrast and postcontrast MRI was 8.0% for gadobutrol and 6.9% for gadopentate dimeglumine. Sensitivity of the average reader was 85.2% for gadobutrol and 88.7% for gadopentate dimeglumine. Specificity of the average reader was 82.1% for gadobutrol and 86.1% for gadopentate dimeglumine. In conclusion, this study documents evidence for the noninferiority of a single i.v. bolus injection of 1.0 M gadobutrol compared with 0.5 M gadopentate dimeglumine in the diagnostic assessment of renal lesions with CE-MRI.
We report the case of a 62-year-old man with chronic pancreatitis who presented with increasing abdominal pain. Sonography, magnetic resonance imaging, contrast-enhanced computed tomography, and ultimately catheter angiography demonstrated a pancreatic pseudocyst that had eroded into the splenoportal venous confluence, mimicking an arterial aneurysm. The diagnostic was confirmed at the time of surgical treatment. This case demonstrates the use of imaging to diagnose complications of pancreatitis, and the difficulty of distinguishing an eroding pseudocyst from an arterial aneurysm.
Background: Because Endomyocardial Biopsy has low sensitivity of about 20%, it can be performed near to myocardium that presented as Late Gadolinium Enhancement (LGE) in cardiovascular magnetic resonance (CMR). However the important issue of comparing topography of CMR and histological findings has not yet been investigated. Thus the current study was performed using an animal model of myocarditis. Results: In 10 male Lewis rats Experimental Autoimmune myocarditis was induced, 10 rats served as control. On day 21 animals were examined by CMR to compare topographic distribution of LGE to histological inflammation. Sensitivity, specificity, positive and negative predictive values for LGE in diagnosing myocarditis were determined for each segment of myocardium. Latter diagnostic values varied widely depending on topographic distribution of LGE and inflammation as well as on the used CMR sequence. Sensitivity of LGE was up to 76% (left lateral myocardium) and positive predictive values were up to 85% (left lateral myocardium), whereas sensitivity and positive predictive value dropped to 0 - 33% (left inferior myocardium). Conclusions: Topographic distribution of LGE and histological inflammation seem to influence sensitivity, specifity, positive and negative predictive values. Nevertheless, positive predictive value for LGE of up to 85% indicates that Endomyocardial Biopsy should be performed "MR-guided". LGE seems to have greater sensitivity than Endomyocardial Biopsy for the diagnosis of myocarditis.
Background & Aims: Thrombopoietin receptor agonists are a new class of compounds licenced for the treatment of immune thrombocytopenic purpura. They are currently being studied for patients with thrombopenia in advanced liver disease or under therapy for hepatitis C. There are indications that the risk for development of portal vein thrombosis in patients with advanced liver cirrhosis might be increased under therapy with thrombopoietin receptor agonists. We report a case of a patient with Child class B liver cirrhosis with concurrent immune thrombocytopenic purpura that developed portal vein thrombosis under therapy with the thrombopoietin receptor agonist romiplostim.
Methods: A 50-year-old woman with hepatitis C virus associated immune thrombocytopenic purpura and Child class B liver cirrhosis presented in our emergency with rapidly evolving hydropic decompensation and general malaise. For immune thrombocytopenic purpura, the patient was started on the thrombopoietin receptor agonist romiplostim nine months ago.
Results: During hospitalization, the platelet count was measured above 330,000/μl and partial portal vein thrombosis was diagnosed by imaging studies. The thrombotic event was assumed to be associated with the romiplostim treatment for immune thrombocytopenic purpura via excessive elevation of platelet count. After anticoagulation with heparin and cessation of romiplostim treatment, complete recanalisation of the portal vein was achieved.
Conclusions: We conclude that romiplostim should be used with precaution in patients with hepatitis C-associated immune thrombocytopenic purpura and advanced liver cirrhosis as the risk for thrombotic complications may increase significantly.
AIM: To evaluate the effect of portal vein thrombosis and arterioportal shunts on local tumor response in advanced cases of unresectable hepatocellular carcinoma treated by transarterial chemoembolization.
METHODS: A retrospective study included 39 patients (mean age: 66.4 years, range: 45-79 years, SD: 7) with unresectable hepatocellular carcinoma (HCC) who were treated with repetitive transarterial chemoembolization (TACE) in the period between March 2006 and October 2009. The effect of portal vein thrombosis (PVT) (in 19 out of 39 patients), the presence of arterioportal shunt (APS) (in 7 out of 39), the underlying liver pathology, Child-Pugh score, initial tumor volume, number of tumors and tumor margin definition on imaging were correlated with the local tumor response after TACE. The initial and end therapy local tumor responses were evaluated according to the response evaluation criteria in solid tumors (RECIST) and magnetic resonance imaging volumetric measurements.
RESULTS: The treatment protocols were well tolerated by all patients with no major complications. Local tumor response for all patients according to RECIST criteria were partial response in one patient (2.6%), stable disease in 34 patients (87.1%), and progressive disease in 4 patients (10.2%). The MR volumetric measurements showed that the PVT, APS, underlying liver pathology and tumor margin definition were statistically significant prognostic factors for the local tumor response (P = 0.018, P = 0.008, P = 0.034 and P = 0.001, respectively). The overall 6-, 12- and 18-mo survival rates from the initial TACE were 79.5%, 37.5% and 21%, respectively.
CONCLUSION: TACE may be exploited safely for palliative tumor control in patients with advanced unresectable HCC; however, tumor response is significantly affected by the presence or absence of PVT and APS.
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic colorectal cancer. Eleven patients with unresectable liver metastases from CRC, tumour burden <30% of liver volume, adequate haematological, liver and renal function, performance status of <2 were included in this study. Patients received up to 4 sessions of TACE with DEBIRI at 3-week intervals. Feasibility of the procedure, safety and tumour response were assessed after each cycle. PK was measured after the first cycle. Patients were followed up to 24 weeks. Only mild to moderate adverse events were observed. DEBIRI is a technically feasibile procedure; no technical complications were observed. Average Cmax for irinotecan and SN-38 was 194 ng/ml and 16.7 ng/ml, respectively, with average t½ of 4.6 h and 12.4 h following administration of DEBIRI. Best overall response during the study showed disease control in 9 patients (2 patients with partial response and 7 with stable disease, overall response rate of 18%). Our study shows that transarterial chemoembolisation with irinotecan-loaded DC beads (DEBIRI) is safe, technically feasible and effective with a good PK profile.
Vasointestinal peptide metabolism plays a key physiological role in multimodular levels of vasodilatory, smooth muscle cell proliferative, parenchymal, and inflammatory lung reactions. In animal studies, vasointestinal peptide relaxes isolated pulmonary arterial segments from several mammalian species in vitro and neutralizes the pulmonary vasoconstrictor effect of endothelin. In some animal models, it reduces pulmonary vascular resistance in vivo and in monocrotaline-induced pulmonary hypertension. A 58-year-old woman presented with dyspnea and mild edema of the lower extremities. A bronchoscopy was performed without any suspicious findings suggesting a central tumor or other infiltrative disease. Endobronchial ultrasound revealed enlarged pulmonary arteries containing thrombi, a few enlarged lymph nodes, and enlarged mediastinal tissue anatomy with suspicion for mediastinal infiltration of a malignant process. We estimated that less than 10% of the peripheral vascular bed of the lung was involved in direct consolidated fibrosis as demonstrated in the left upper lobe apex. Further, direct involvement of fibrosis around the main stems of the pulmonary arteries was assumed to be low from positron emission tomography and magnetic resonance imaging scans. Assuming a positive influence of low-dose radiation, it was not expected that this could have reduced pulmonary vascular resistance by over two thirds of the initial result. However; it was noted that this patient had idiopathic pulmonary arterial hypertension mixed with "acute" (mediastinal) fibrosis which could have contributed to the unexpected success of reduction of pulmonary vascular resistance. To the best of our knowledge, this is the first report of successful treatment of idiopathic pulmonary arterial hypertension, probably as a result of low-dose radiation to the pulmonary arterial main stems. The patient continues to have no specific complaints concerning her idiopathic pulmonary arterial hypertension.
Introduction: Currently there are several advanced guiding techniques for pathoanatomical diagnosis of incidental solitary pulmonary nodules (iSPN): Electromagnetic navigation (EMN) with or without endobronchial ultrasound (EBUS) with miniprobe, transthoracic ultrasound (TTUS) for needle approach to the pleural wall and adjacent lung and computed tomography (CT) -guidance for (seldom if ever used) endobronchial or (common) transthoracical approach. In several situations one technique is not enough for efficient diagnosis, therefore we investigated a new diagnostic technique of endobronchial guided biopsies by a Cone Beam Computertomography (CBCT) called DynaCT (SIEMENS AG Forchheim, Germany). Method and Material: In our study 33 incidental solitary pulmonary nodules (iSPNs) (28 malignant, 5 benign; mean diameter 25 +/-12mm, shortest distance to pleura 25+/-18mm) were eligible according to in- and exclusion criteria. Realtime and onsite navigation were performed according to our standard protocol.22 All iSPN were controlled with a second technique when necessary and clinical feasible in case of unspecific or unexpected histological result. In all cases common guidelines of treatment of different iSPNs were followed in a routine manner. Results: Overall navigational yield (ny) was 91% and diagnostic yield (dy) 70%, dy for all accomplished malignant cases (n=28) was 82%. In the subgroup analysis of the invisible iSPN (n=12, 11 malignant, 1 benign; mean diameter 15+/-3mm) we found an overall dy of 75%. For the first time we describe a significant difference in specifity of biopsy results in regards to the position of the forceps in the 3-dimensional volume (3DV) of the iSPN in the whole sample group. Comparing the specifity of biopsies of a 3D-uncentered but inside the outer one third of an iSPN-3DV with the specifity of biopsies of centered forceps position (meaning the inner two third of an iSPN-3DV) reveals a significant (p=0,0375 McNemar) difference for the size group (>1cm) of 0,9 for centered biopsies vs. 0,3 for uncentered biopsies. Therefore only 3D-centered biopsies should be relied on especially in case of a benign result. Conclusion:The diagnostic yield of DynaCT navigation guided transbronchial biopsies (TBB) only with forceps is at least up to twofold higher than conventional TBB for iSPNs <2cm. The diagnostic yield of DynaCT navigation guided forceps TBB in invisible SPNs is at least in the range of other navigation studies which were performed partly with multiple navigation tools and multiple instruments. For future diagnostic and therapeutic approaches it is so far the only onsite and realtime extrathoracic navigation approach (except for computed tomography (CT)-fluoroscopy) in the bronchoscopy suite which keeps the working channel open. The system purchase represents an important investment for hospitals but it is a multidisciplinary and multinavigational tool with possible access via bronchial airways, transthoracical or vascular approach at the same time and on the same table without the need for an expensive disposable instrument use.